CompletedPhase 2NCT02249949
Efatutazone Dihydrochloride in Treating Patients With Previously Treated Myxoid Liposarcoma That Cannot Be Removed by Surgery
Studying Myxoid/round cell liposarcoma
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Alliance for Clinical Trials in Oncology
- Principal Investigator
- Michael Pishvaian, MD, PhDGeorgetown University
- Intervention
- efatutazone(drug)
- Enrollment
- 15 enrolled
- Eligibility
- 18 years · All sexes
- Timeline
- 2015 – 2023
Study locations (30)
- University of Arkansas for Medical Sciences, Little Rock, Arkansas, United States
- University of Colorado Hospital, Aurora, Colorado, United States
- Yale University, New Haven, Connecticut, United States
- MedStar Georgetown University Hospital, Washington D.C., District of Columbia, United States
- MedStar Washington Hospital Center, Washington D.C., District of Columbia, United States
- Northside Hospital, Atlanta, Georgia, United States
- Northside Hospital-Forsyth, Cumming, Georgia, United States
- Hawaii Cancer Care Inc-POB II, Honolulu, Hawaii, United States
- Hawaii Oncology Inc-POB I, Honolulu, Hawaii, United States
- Island Urology, Honolulu, Hawaii, United States
- Queen's Medical Center, Honolulu, Hawaii, United States
- Straub Clinic and Hospital, Honolulu, Hawaii, United States
- University of Hawaii Cancer Center, Honolulu, Hawaii, United States
- Hawaii Cancer Care Inc-Liliha, Honolulu, Hawaii, United States
- Hawaii Oncology Inc-Kuakini, Honolulu, Hawaii, United States
- +15 more locations on ClinicalTrials.gov
Collaborators
National Cancer Institute (NCI) · Daiichi Sankyo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02249949 on ClinicalTrials.govOther trials for Myxoid/round cell liposarcoma
Additional recruiting or active studies for the same condition.
- RECRUITINGPHASE1NCT06644755First-in-Human Trial of DS-2243a in Participants With Advanced Solid TumorsDaiichi Sankyo
- RECRUITINGPHASE1NCT06414434BTX-A51 in Patients With Liposarcoma or CIC-rearranged SarcomaMichael Wagner, MD
- RECRUITINGPHASE1NCT06083883Phase I/Ib Study of NK Expressing an Affinity-enhanced T-cell Receptor (TCR) Against the NY-ESO-1M.D. Anderson Cancer Center
- ACTIVE NOT RECRUITINGPHASE1NCT05492682START: Safety and Anti-Tumor Activity of PeptiCRAd-1 in Treatment of CancerValo Therapeutics Oy
- ACTIVE NOT RECRUITINGPHASE2NCT04044768Spearhead 1 Study in Subjects With Advanced Synovial Sarcoma or Myxoid/Round Cell LiposarcomaUSWM CT, LLC